雜志介紹

International Journal Of Radiation Oncology Biology Physics雜志介紹

《International Journal Of Radiation Oncology Biology Physics》是一本以English為主的未開放獲取國際優秀期刊，中文名稱國際放射腫瘤學生物學物理學雜志，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為6.4，最新CiteScore 指數為11。

本刊近期中國學者發表的論文主要有：

• Phenylephrine Alleviates 131I Radiation Damage in Submandibular Gland Through Maintaining Mitochondrial Homeostasis

  Author: Xin Yue Wang, Jing Yu, Fu Yin Zhang, Ke Jian Liu, Bin Xiang

• Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy

  Author: Cheng-En Hsieh, Bhanu Prasad Venkatesulu, Ching-Hsin Lee, Sheng-Ping Hung, Pei-Fong Wong, Sathvik Panambur Aithala, Byung Kyu Kim, Arvind Rao, Joseph Tung-Chieh Chang, Ngan-Ming Tsang, Chun-Chieh Wang, Chung-Chi Lee, Chen-Chun Lin, Jeng-Hwei Tseng, Wen-Chi Chou, Yu-Chao Wang, Sunil Krishnan, Ji-Hong Hong

• Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design

  Author: Xiaofei Zhu, Xiaoping Ju, Yangsen Cao, Yuxin Shen, Fei Cao, Shuiwang Qing, Fang Fang, Zhen Jia, Huojun Zhang

• Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma

  Author: Cheng-Long Huang, Zheng-Qiang Sun, Rui Guo, Xu Liu, Yan-Ping Mao, Hao Peng, Li Tian, Ai-Hua Lin, Li Li, Jian-Yong Shao, Ying Sun, Jun Ma, Ling-Long Tang

英文介紹

International Journal Of Radiation Oncology Biology Physics雜志英文介紹

International Journal of Radiation Oncology ? Biology ? Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.

This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.